196 related articles for article (PubMed ID: 8454112)
1. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
O'Brien RC; Cooper ME; Jerums G; Doyle AE
Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112
[TBL] [Abstract][Full Text] [Related]
2. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
Cooper ME; Rumble JR; Allen TJ; O'Brien RC; Jerums G; Doyle AE
Kidney Int; 1992 Apr; 41(4):898-903. PubMed ID: 1513111
[TBL] [Abstract][Full Text] [Related]
4. Perindopril ameliorates glomerular and renal tubulointerstitial injury in the SHR/N-corpulent rat.
Velasquez MT; Striffler JS; Abraham AA; Michaelis OE; Scalbert E; Thibault N
Hypertension; 1997 Nov; 30(5):1232-7. PubMed ID: 9369281
[TBL] [Abstract][Full Text] [Related]
5. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
Cooper ME; Allen TJ; O'Brien RC; Papazoglou D; Clarke BE; Jerums G; Doyle AE
Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
[TBL] [Abstract][Full Text] [Related]
6. Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
Duggan KA; Hodge G; Makarious MM; Charlesworth JA
Clin Sci (Lond); 1998 May; 94(5):511-6. PubMed ID: 9682674
[TBL] [Abstract][Full Text] [Related]
7. Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors.
Cooper ME; Rumble JR; Gin T; Lim-Joon T
Clin Exp Pharmacol Physiol Suppl; 1992; 19():23-7. PubMed ID: 1395113
[TBL] [Abstract][Full Text] [Related]
8. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy.
Fujihara CK; Padilha RM; Zatz R
Diabetes; 1992 Mar; 41(3):286-93. PubMed ID: 1551488
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats.
Yan L; Yang R; Cheng H; Fu Z; Zhong G; Yan T
Chin Med J (Engl); 1998 Apr; 111(4):306-8. PubMed ID: 10374392
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
Anderson S; Rennke HG; Brenner BM
J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
[TBL] [Abstract][Full Text] [Related]
11. Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.
Wilkinson-Berka JL; Gibbs NJ; Cooper ME; Skinner SL; Kelly DJ
Nephrol Dial Transplant; 2001 Jul; 16(7):1343-9. PubMed ID: 11427623
[TBL] [Abstract][Full Text] [Related]
12. The comparative effects of perindopril and catechin on mesangial matrix and podocytes in the streptozotocin induced diabetic rats.
Ertürküner SP; Başar M; Tunçdemir M; Seçkin İ
Pharmacol Rep; 2014 Apr; 66(2):279-87. PubMed ID: 24911082
[TBL] [Abstract][Full Text] [Related]
13. Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes.
Erensoy N; Yilmazer S; Oztürk M; Tunçdemir M; Uysal O; Hatemi H
Acta Histochem; 2004; 106(4):279-87. PubMed ID: 15350810
[TBL] [Abstract][Full Text] [Related]
14. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
Fabris B; Candido R; Armini L; Fischetti F; Calci M; Bardelli M; Fazio M; Campanacci L; Carretta R
J Hypertens; 1999 Dec; 17(12 Pt 2):1925-31. PubMed ID: 10703891
[TBL] [Abstract][Full Text] [Related]
15. Renal function, glycemic control and perindopril in diabetic patients.
Brichard S; Ketelslegers JM; Lambert AE
Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model.
Raij L; Chiou XC; Owens R; Wrigley B
Am J Med; 1985 Sep; 79(3C):37-41. PubMed ID: 2996345
[TBL] [Abstract][Full Text] [Related]
17. Short and long term effects of antihypertensive therapy in the diabetic rat.
Anderson S; Rennke HG; Garcia DL; Brenner BM
Kidney Int; 1989 Oct; 36(4):526-36. PubMed ID: 2681929
[TBL] [Abstract][Full Text] [Related]
18. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice.
Zhang MZ; Wang S; Yang S; Yang H; Fan X; Takahashi T; Harris RC
Am J Physiol Renal Physiol; 2012 Feb; 302(4):F433-8. PubMed ID: 22114203
[TBL] [Abstract][Full Text] [Related]
19. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
BMJ; 1991 Jan; 302(6770):210-6. PubMed ID: 1998761
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
Kelly DJ; Zhang Y; Hepper C; Gow RM; Jaworski K; Kemp BE; Wilkinson-Berka JL; Gilbert RE
Diabetes; 2003 Feb; 52(2):512-8. PubMed ID: 12540629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
